Endoc Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-06-2024
- Paid Up Capital ₹ 2.10 Cr
as on 23-06-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 36.00 Cr
as on 23-06-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth 2000.00%
(FY 2023)
- Total Assets 581.57%
(FY 2023)
About Endoc Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.10 Cr.
The company currently has active open charges totaling ₹36.00 Cr.
Jigneshkumar Akbari, Suresh Sorathiya, Ghanashyam Harsoda, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304GJ2020PTC112449
- Company No.
112449
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Endoc Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ghanashyam Harsoda  | Director | 31-Jan-2020 | Current |
| Suresh Sorathiya | Director | 31-Jan-2020 | Current |
| Jigneshkumar Akbari | Director | 31-Jan-2020 | Current |
| Vinodkumar Asodariya | Director | 31-Jan-2020 | Current |
Financial Performance of Endoc Biotech.
Endoc Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 2000%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Endoc Biotech?
Unlock access to Endoc Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Snj Lifecare Private LimitedActive 4 years 11 monthsJigneshkumar Akbari and Suresh Sorathiya are mutual person
Rajkot Engineering Testing And Research CentreActive 13 years 2 monthsVinodkumar Asodariya is a mutual person
Nira Life Sciences Private LimitedActive 12 years 10 monthsSuresh Sorathiya and Ghanashyam Harsoda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 Feb 2023 | ₹36.00 Cr | Open |
How Many Employees Work at Endoc Biotech?
Unlock and access historical data on people associated with Endoc Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Endoc Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endoc Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
